Status: Recruiting
A Study of Bleeding and Treatment in Participants With Von Willebrand Disease
The purpose of this screening study is to accumulate information regarding bleeding events, quality of life, and the social and clinical impact of bleeds in participants with Von Willebrand Disease (VWD). Data from this study will be used to establish baseline bleeding and treatment rates in a population of participants with VWD and act as comparator data for future clinical study outcomes.(e.g. Velora Pioneer)
Participants needed: 200
Trial details
Age: 16+Biological sex: AllType: ObservationalSponsor: Hemab ApSUpdated: Apr 21, 2026Locations: 17
Eligibility criteria
Has the ability to provide informed consent to participate in the study, in acco... [+5]
Has a history of clinically significant hypersensitivity associated with monoclo... [+11]